299 related articles for article (PubMed ID: 30926297)
21. Vaccine effectiveness against influenza A(H3N2) and B among laboratory-confirmed, hospitalised older adults, Europe, 2017-18: A season of B lineage mismatched to the trivalent vaccine.
Rose AMC; Kissling E; Gherasim A; Casado I; Bella A; Launay O; Lazăr M; Marbus S; Kuliese M; Syrjänen R; Machado A; Kurečić Filipović S; Larrauri A; Castilla J; Alfonsi V; Galtier F; Ivanciuc A; Meijer A; Mickiene A; Ikonen N; Gómez V; Lovrić Makarić Z; Moren A; Valenciano M;
Influenza Other Respir Viruses; 2020 May; 14(3):302-310. PubMed ID: 32022450
[TBL] [Abstract][Full Text] [Related]
22. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y
J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914
[TBL] [Abstract][Full Text] [Related]
23. Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: A test-negative study.
Lytras T; Kossyvakis A; Melidou A; Andreopoulou A; Exindari M; Gioula G; Kalliaropoulos A; Tryfinopoulou K; Pogka V; Spala G; Malisiovas N; Mentis A
J Med Virol; 2016 Nov; 88(11):1896-904. PubMed ID: 27088266
[TBL] [Abstract][Full Text] [Related]
24. Epidemiological and virological characteristics of influenza viruses circulating in Cambodia from 2009 to 2011.
Horm SV; Mardy S; Rith S; Ly S; Heng S; Vong S; Kitsutani P; Ieng V; Tarantola A; Ly S; Sar B; Chea N; Sokhal B; Barr I; Kelso A; Horwood PF; Timmermans A; Hurt A; Lon C; Saunders D; Ung SA; Asgari N; Roces MC; Touch S; Komadina N; Buchy P
PLoS One; 2014; 9(10):e110713. PubMed ID: 25340711
[TBL] [Abstract][Full Text] [Related]
25. Antigenic Drift of A/H3N2/Virus and Circulation of Influenza-Like Viruses During the 2014/2015 Influenza Season in Poland.
Bednarska K; Hallmann-Szelińska E; Kondratiuk K; Brydak LB
Adv Exp Med Biol; 2016; 905():33-8. PubMed ID: 26956457
[TBL] [Abstract][Full Text] [Related]
26. Genetic changes in influenza A(H3N2) viruses circulating during 2011 to 2013 in northern India (Lucknow).
Jain A; Dangi T; Jain B; Singh AK; Singh JV; Kumar R
J Med Virol; 2015 Aug; 87(8):1268-75. PubMed ID: 25914198
[TBL] [Abstract][Full Text] [Related]
27. Virological surveillance of influenza and other respiratory viruses during six consecutive seasons from 2006 to 2012 in Catalonia, Spain.
Antón A; Marcos MA; Torner N; Isanta R; Camps M; Martínez A; Domínguez A; Jané M; Jiménez de Anta MT; Pumarola T
Clin Microbiol Infect; 2016 Jun; 22(6):564.e1-9. PubMed ID: 26939538
[TBL] [Abstract][Full Text] [Related]
28. Phylogenetic analysis of HA and NA genes of influenza A viruses in immunosuppressed inpatients in Beijing during the 2018-2020 influenza seasons.
Liu Y; Wang Y; Wang Y; Mai H; Chen Y; Zhang Y; Ji Y; Cong X; Gao Y
Virol J; 2023 May; 20(1):101. PubMed ID: 37237356
[TBL] [Abstract][Full Text] [Related]
29. Genetic and antigenic characterization of influenza A(H1N1)pdm09 in Yantai, China, during the 2009-2017 influenza season.
Liu J; Gong LF; Xu YC; Sun ZL; Gao Q; Dong ZJ
J Med Virol; 2019 Mar; 91(3):351-360. PubMed ID: 30267587
[TBL] [Abstract][Full Text] [Related]
30. Predominance of influenza A(H1N1)pdm09 virus genetic subclade 6B.1 and influenza B/Victoria lineage viruses at the start of the 2015/16 influenza season in Europe.
Broberg E; Melidou A; Prosenc K; Bragstad K; Hungnes O;
Euro Surveill; 2016; 21(13):. PubMed ID: 27074657
[TBL] [Abstract][Full Text] [Related]
31. Influenza vaccine effectiveness against laboratory-confirmed influenza in hospitalised adults aged 60 years or older, Valencia Region, Spain, 2017/18 influenza season.
Mira-Iglesias A; López-Labrador FX; Baselga-Moreno V; Tortajada-Girbés M; Mollar-Maseres J; Carballido-Fernández M; Schwarz-Chavarri G; Puig-Barberà J; Díez-Domingo J;
Euro Surveill; 2019 Aug; 24(31):. PubMed ID: 31387672
[TBL] [Abstract][Full Text] [Related]
32. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
[TBL] [Abstract][Full Text] [Related]
33. Changes in the hemagglutinins and neuraminidases of human influenza B viruses isolated in Italy during the 2001-02, 2002-03, and 2003-04 seasons.
Puzelli S; Frezza F; Fabiani C; Ansaldi F; Campitelli L; Lin YP; Gregory V; Bennett M; D'Agaro P; Campello C; Crovari P; Hay A; Donatelli I
J Med Virol; 2004 Dec; 74(4):629-40. PubMed ID: 15484280
[TBL] [Abstract][Full Text] [Related]
34. Predominance of influenza virus A(H3N2) 3C.2a1b and A(H1N1)pdm09 6B.1A5A genetic subclades in the WHO European Region, 2018-2019.
Melidou A; Hungnes O; Pereyaslov D; Adlhoch C; Segaloff H; Robesyn E; Penttinen P; Olsen SJ;
Vaccine; 2020 Jul; 38(35):5707-5717. PubMed ID: 32624252
[TBL] [Abstract][Full Text] [Related]
35. The evolution of human influenza A viruses from 1999 to 2006: a complete genome study.
Bragstad K; Nielsen LP; Fomsgaard A
Virol J; 2008 Mar; 5():40. PubMed ID: 18325125
[TBL] [Abstract][Full Text] [Related]
36. Interim estimates of divergence date and vaccine strain match of human influenza A(H3N2) virus from systematic influenza surveillance (2010-2015) in Hangzhou, southeast of China.
Li J; Zhou YY; Kou Y; Yu XF; Zheng ZB; Yang XH; Wang HQ
Int J Infect Dis; 2015 Nov; 40():17-24. PubMed ID: 26417878
[TBL] [Abstract][Full Text] [Related]
37. [Molecular characterization of human influenza viruses--a look back on the last 10 years].
Schweiger B
Berl Munch Tierarztl Wochenschr; 2006; 119(3-4):167-78. PubMed ID: 16573207
[TBL] [Abstract][Full Text] [Related]
38. Improving influenza virological surveillance in Europe: strain-based reporting of antigenic and genetic characterisation data, 11 European countries, influenza season 2013/14.
Broberg E; Hungnes O; Schweiger B; Prosenc K; Daniels R; Guiomar R; Ikonen N; Kossyvakis A; Pozo F; Puzelli S; Thomas I; Waters A; Wiman Å; Meijer A
Euro Surveill; 2016 Oct; 21(41):. PubMed ID: 27762211
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results.
Andrews N; McMenamin J; Durnall H; Ellis J; Lackenby A; Robertson C; von Wissmann B; Cottrell S; Smyth B; Moore C; Gunson R; Zambon M; Fleming D; Pebody R
Euro Surveill; 2014 Jul; 19(27):5-13. PubMed ID: 25033051
[TBL] [Abstract][Full Text] [Related]
40. Assessing the Intense Influenza A(H1N1)pdm09 Epidemic and Vaccine Effectiveness in the Post-COVID Season in the Russian Federation.
Sominina A; Danilenko D; Komissarov AB; Pisareva M; Fadeev A; Konovalova N; Eropkin M; Petrova P; Zheltukhina A; Musaeva T; Eder V; Ivanova A; Komissarova K; Stolyarov K; Karpova L; Smorodintseva E; Dorosh A; Krivitskaya V; Kuznetzova E; Majorova V; Petrova E; Boyarintseva A; Ksenafontov A; Shtro A; Nikolaeva J; Bakaev M; Burtseva E; Lioznov D
Viruses; 2023 Aug; 15(8):. PubMed ID: 37632122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
